3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Hereditary Sensory and Autonomic Neuropathies
3
Small Cell Lung Carcinoma
1
Advanced Solid Tumor
1
Interventions
Injections
24
pembrolizumab
13
toripalimab
12
tislelizumab
9
Gemcitabine
7
Cisplatin
7
Carboplatin
6
atezolizumab
5
Nivolumab
5
Irinotecan
5
Pemetrexed
4
Oxaliplatin
4
Leucovorin
4
Fluorouracil
4
Docetaxel
4
Cetuximab
4
trastuzumab deruxtecan
3
spartalizumab
3
cediranib
3
Paclitaxel
3
PM 01183
3
Capecitabine
3
sintilimab
2
olaparib
2
lenvatinib
2
glumetinib
2
camrelizumab
2
apatinib
2
Therapeutics
2
Midazolam
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Advanced Solid Tumor
×
berzosertib
×
Clear all
NCT02157792
2020-04-01
M6620 First in Human Study
EMD Serono
Phase 1
Completed
200 enrolled